Shanghai wants to regain the leading position of biomedicine: clear development of modern Chinese medicine and other four directions

News reporter zang Ming 2017-08-30 source: paper news

      On August 30, "Shanghai to promote healthy development of the biomedicine industry implementation opinion" issued, clear in 2020, the Shanghai biological medicine industry innovation ability to maintain the leading position nationwide, the main business income reached 380 billion yuan of above, built in the asia-pacific region basic biological medicine industry high-end product r&d center, manufacturing center, outsourcing and service center and modern medicine circulation system capable of allocation of global resources.

      Biological medicine industry is the national strategic emerging industry development planning ", "much starker choices-and graver consequences-in" five $10 trillion level in one of pillar industries, and focus on the development of strategic emerging industries in Shanghai. The development of biomedical industry is of great significance to promote the optimization and upgrading of the industrial structure in Shanghai and cultivate the new kinetic energy.

      In the 1990s, Shanghai was the first place in the country to maintain the first place in the pharmaceutical industry, and in recent years, the national pharmaceutical industry's main business income ranking has slipped to the domestic middle level.

      Today, the Shanghai national biomedical industry "leader" status, industry development faces many challenges, such as lack of leading enterprises, innovative results, a large number of outflow, inadequate research and development, product difficult into health care and so on. Therefore, the Shanghai biopharmaceuticals industry urgently needs to strengthen policy guidance, further cultivate the leading enterprises, accelerate the transformation and development of the industry, and encourage the promotion of innovation and results.

      According to the Shanghai promote the healthy development of the biomedicine industry implementation opinion ", Shanghai will promote the independent innovation ability, the construction of the world's leading biomedical innovation research and development center, seize the Shanghai centre kechuang with global influence to speed up the construction of historical opportunity, the construction of infrastructure large translational medicine research center, science and technology, the implementation of international human phenotype group and other major scientific plan, promoting Shanghai biological medicine industry technology and clinical research functional platform construction.

      Advantages of Shanghai will focus on key areas, to build internationally renowned high-end biomedical products manufacturing center, including the priority to the development of biological products, focus on developing sustainable development of chemical drugs, medical apparatus and instruments, promote the development of modern Chinese medicine four direction.

      At the same time, Shanghai will foster new industry formats, demonstration center construction of biological medicine research and development outsourcing and health services, including advance drug marketing authorisation holder system pilot, pilot medical apparatus and instruments in the free trade area registration applicant entrust Shanghai medical device manufacturing enterprise production products.

      Shanghai will make pharmaceutical supply chain highlands, establish modern medicine circulation system capable of allocation of global resources, including establish international pharmaceutical trading center feasibility study, support the wisdom medical supply chain model demonstration base of enterprise and innovation, improve the full traceability pharmaceutical supply chain traceability system.

      In addition, Shanghai will also enhance matching and quality system, and promote the development of biological medicine industry agglomeration, transformation and health, including propulsion model of intelligent manufacturing and construction, strengthen consciousness of quality and safety of the first pharmaceutical enterprises. Guide the industry to cluster in related areas, and promote the transformation of manufacturing industry to biopharmaceuticals, high-end preparations and high-end medical devices.